Severity: Critical Alert
Exit/Entry: Cyprus maintaining COVID-19-related entry restrictions as of Sept. 15; domestic mandatory social-distancing measures remain.
Alert Begins 15 Sep 2020 03:52 PM UTC
Alert Expires 30 Sep 2020 11:59 PM UTC
- Event: COVID-19 restrictions
- Location(s): Nationwide (map)
- Time Frame: Indefinite
- Impact: Travel and business disruptions
As of Sept. 15, authorities in Cyprus are maintaining international entry restrictions to curb the spread of coronavirus disease (COVID-19). Authorities have divided countries into three categories. Travelers from countries in Category A do not need to present a negative COVID-19 test upon arrival; travelers from countries listed in Category B do require a negative COVID-19 test taken 72 hours prior to departure for Cyprus. Travelers from Category C countries - with the exception of Cypriot residents, their immediate families, and individuals with special entry permission to perform essential work - are prohibited from entering Cyprus.
The categories as of Sept. 15 are as follows:
- Category A: Canada, Estonia, Finland, Georgia, Germany, Latvia, Lithuania, New Zealand, Norway, South Korea, and Thailand
- Category B: Australia, Austria, Belgium, China (including Hong Kong), Czech Republic, Denmark, Greece, Hungary, Iceland, Ireland, Italy, Japan, Liechtenstein, and Vatican City
- Category C: All other countries
Domestically, most businesses have resumed operations with government-mandated social distancing and hygiene requirements. Protective face coverings are necessary for several enclosed public spaces. Additionally, privately organized gatherings are limited to 75 people indoors or 150 people outdoors.
Authorities could reimpose, extend, further ease, or otherwise amend restrictions with little-to-no notice depending on disease activity over the coming weeks.
Background and Analysis
The measures implemented in Cyprus are similar to actions undertaken by other regional governments as part of ongoing efforts to curb the spread of COVID-19. COVID-19 is a viral respiratory disease caused by infection with the SARS-CoV-2 virus (previously known as 2019-nCoV). Symptoms occur 1-14 days following exposure (average of 3-7 days). These symptoms include fever, fatigue, cough, difficulty breathing, sometimes worsening to pneumonia and kidney failure - especially in those with underlying medical conditions.
Authorities could reintroduce sporadic, highly targeted measures in response to local COVID-19 outbreaks. Such measures could apply to neighborhoods or specific facilities, including schools, factories, or accommodation and office blocks. Mandatory social-distancing procedures in public places and on public transport, as well as widespread voluntary "self-policing" by residents, will assist in reducing the potential for contagion, negating the necessity for a large-scale, blanket reintroduction of significant restrictions.
Follow all official instructions. Abide by national health and safety measures. Reconfirm all travel arrangements. Consider delaying traveling if experiencing symptoms associated with COVID-19, as they may prompt increased scrutiny and delays. Liaise with trusted contacts for further updates and guidance. Maintain contact with your diplomatic representation. Ensure contingency plans account for further disruptive measures or extensions of current restrictions. Reconsider and reconfirm nonemergency health appointments.
Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.